HomeCompareMLLUY vs MRK

MLLUY vs MRK: Dividend Comparison 2026

MLLUY yields 3.64% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLLUY wins by $1099.46M in total portfolio value
10 years
MLLUY
MLLUY
● Live price
3.64%
Share price
$4.29
Annual div
$0.16
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1099.52M
Annual income
$1,044,382,448.77
Full MLLUY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MLLUY vs MRK

📍 MLLUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLLUYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLLUY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLLUY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLLUY
Annual income on $10K today (after 15% tax)
$309.31/yr
After 10yr DRIP, annual income (after tax)
$887,725,081.45/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MLLUY beats the other by $887,716,753.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLLUY + MRK for your $10,000?

MLLUY: 50%MRK: 50%
100% MRK50/50100% MLLUY
Portfolio after 10yr
$549.79M
Annual income
$522,196,123.45/yr
Blended yield
94.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MLLUY
No analyst data
Altman Z
0.8
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLLUY buys
0
MRK buys
0
No recent congressional trades found for MLLUY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLLUYMRK
Forward yield3.64%2.76%
Annual dividend / share$0.16$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1099.52M$56.8K
Annual income after 10y$1,044,382,448.77$9,798.13
Total dividends collected$1095.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MLLUY vs MRK ($10,000, DRIP)

YearMLLUY PortfolioMLLUY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,428$727.79$11,206$366.19+$222.00MLLUY
2$13,782$1,554.58$12,650$502.35+$1.1KMLLUY
3$18,251$3,504.43$14,407$694.19+$3.8KMLLUY
4$28,204$8,674.42$16,585$967.82+$11.6KMLLUY
5$55,233$25,054.85$19,342$1,363.89+$35.9KMLLUY
6$150,812$91,712.85$22,913$1,947.19+$127.9KMLLUY
7$629,444$468,075.52$27,662$2,823.89+$601.8KMLLUY
8$4,325,113$3,651,607.74$34,159$4,173.35+$4.29MMLLUY
9$51,527,631$46,899,760.13$43,337$6,308.80+$51.48MMLLUY
10$1,099,517,014$1,044,382,448.77$56,776$9,798.13+$1099.46MMLLUY

MLLUY vs MRK: Complete Analysis 2026

MLLUYStock

Metallurgical Corporation of China Ltd., together with its subsidiaries, engages in the engineering contracting, property development, equipment manufacture, and resource development businesses in China and internationally. The company's Engineering Contracting segment offers engineering, construction, and other related contracting services for metallurgical and non-metallurgical projects. Its Property Development segment develops and sells residential and commercial properties, and housing properties; and develops land. The company's Equipment Manufacturing segment engages in the development and production of metallurgical equipment, steel structures, and other metal products. Its Resource Development segment is involved in the development, mining, and processing of mineral resources; and the production of nonferrous metals and polysilicon. The company was founded in 2008 and is based in Beijing, the People's Republic of China.

Full MLLUY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MLLUY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLLUY vs SCHDMLLUY vs JEPIMLLUY vs OMLLUY vs KOMLLUY vs MAINMLLUY vs JNJMLLUY vs ABBVMLLUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.